Skip to main content
. 2024 Dec 3;31(12):7738–7753. doi: 10.3390/curroncol31120569
Reviewer Ratings (N = 2)
Question Lowest Quality
(1)
(2) Neutral (3) (4) Highest Quality
(5)
  1. Rate the guideline development methods.

2
  • 2.

    Rate the guideline presentation.

2
  • 3.

    Rate the guideline recommendations.

2
  • 4.

    Rate the completeness of reporting.

1 1
  • 5.

    Does this document provide sufficient information to inform your decisions? If not, what areas are missing?

2
  • 6.

    Rate the overall quality of the guideline report.

2
Strongly Disagree
(1)
(2) Neutral (3) (4) Strongly Agree
(5)
  • 7.

    I would make use of this guideline in my professional decisions.

2
  • 8.

    I would recommend this guideline for use in practice.

2
  • 9.

    What are the barriers or enablers to the implementation of this guideline report?

None listed.
Comments Responses
1. The role of post operative imaging in the management of close and positive DCIS margins was not mentioned. Does more imaging to determine obvious residual disease play a role in the decision to re-excise vs. boost radiation? We have added a qualifying statement to Recommendation 1: The use of imaging modalities to assess for residual disease in patients with positive markings post BCS is outside the scope of this guideline but the Working Group consensus favors positive margins being treated surgically given perceived low sensitivity for detecting residual disease versus postoperative changes in patients having undergone recent surgery with all imaging modalities.